Original ArticleBarium tungstate nanoparticles to enhance radiation therapy against cancer
Graphical Abstract
BaWO4 nanoparticles were prepared and tested as a novel type of radiosensitizer. Containing high-Z elements (Ba and W), BaWO4 nanoparticles can enhance the production of radicals under radiation. Our results show that BaWO4 nanoparticles have lower toxicity than CaWO4 nanoparticles in the absence of radiation but lead to higher cellular oxidative stress in vitro and greater tumor suppression in vivo.
Section snippets
Chemicals
Barium chloride (BaCl2, anhydrous, ≥97%, Fisher Scientific), calcium chloride (CaCl2, anhydrous, ≥97%, Millipore Sigma), sodium tungstate dihydrate (Na2WO4·2H2O, ≥99%, Fisher Scientific), hexadecyltrimethylammonium bromide (CTAB, ≥99%, Millipore Sigma), PVP (MW 360,000, Millipore Sigma), thiazolyl blue tetrazolium bromide (MTT, ≥97.5%, HPLC, Millipore Sigma), 3′-(p-aminophenyl) fluorescein (APF, Life Technologies), singlet oxygen sensor green (SOSG, Life Technologies), superoxide dismutase
Results and Discussion
BaWO4 nanoparticles were synthesized through a hydrothermal reaction. Briefly, CTAB was dissolved in cyclohexane/1-hexanol, and was added into an aqueous solution containing BaCl2 and Na2WO4. The resulting mixture underwent vigorous stirring at 70 °C for 1 minute before transferred to a Teflon-lined autoclave. The autoclave was heated at 160 °C for 24 h, and then cooled down to room temperature. The products were collected by centrifugation. Transmission electron microscopy (TEM) and scanning
Conclusions
We have synthesized PVP-coated BaWO4 nanoparticles and assessed their potential as a novel type of radiosensitizer. For comparison, we have also studied CaWO4 nanoparticles, another type of alkaline earth metal tungstate. Previously, high-Z nanoparticles made of gold, HfO2, as well as gadolinium, silver, bismuth, and iron oxide, have been tested for their radiosensitizing effects.11,16., 17., 18.,20,32., 33., 34., 35. To our best knowledge, BaWO4 nanoparticles have never been investigated for
Acknowledgement
We thank the funding support by the National Natural Science Foundation of China (NSFC) projects (Grant numbers: 81871384, 81771869, 81571708), the Norman Bethune Program of Jilin University (Grant number: 2015219), the Research Fund of Science and Technology Department of Jilin Province (Grant number: 20200201414), and the Hygiene Specific Subjects of Jilin Province (Grant number: 2018SCZ039). This work was also supported by a UGA-Augusta seed grant.
Notes
The authors declare no competing financial interest.
References (35)
- et al.
Effects of radiation on normal tissue: consequences and mechanisms
Lancet Oncol
(2003) - et al.
Cancer radiosensitizers
Trends Pharmacol Sci
(2018) Chemical radiosensitizers for use in radiotherapy
Clin Oncol
(2007)- et al.
Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy
J Control Release
(2016) - et al.
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (act. In. Sarc): a multicentre, phase 2–3, randomised, controlled trial
Lancet Oncol
(2019) - et al.
Scintillation properties and radioactive contamination of CaWO4 crystal scintillators
Nucl Instrum Meth A
(2005) - et al.
Evidence for free radical formation during the oxidation of 2′-7′-dichlorofluorescin to the fluorescent dye 2′-7′-dichlorofluorescein by horseradish peroxidase: possible implications for oxidative stress measurements
Free Radical Bio Med
(1999) - et al.
The integration of radiotherapy with immunotherapy for the treatment of non–small cell lung cancer
Clin Cancer Res
(2018) - et al.
A critical review of recent developments in radiotherapy for non-small cell lung cancer
Radiat Oncol
(2016) - et al.
Hypofractionated radiation therapy for early breast cancer
Cochrane DB Syst Rev
(2016)
Newly diagnosed glioblastoma: a review on clinical management
Brain
The current status of treatment for colorectal cancer in China: A systematic review
Medicine
Nanoparticles encapsulating nitrosylated maytansine to enhance radiation therapy
ACS Nano
Acridine orange encapsulated mesoporous manganese dioxide nanoparticles to enhance radiotherapy
Bioconjug Chem
Emerging nanotechnology and advanced materials for cancer radiation therapy
Adv Mater
Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer
Mol Pharm
Cited by (0)
- 1
These authors contributed equally to this work.